The mammalian Cks (Cks1 and Cks2) proteins are small molecular weight ( about 9kDa) proteins that are highly related evolutionarily to the yeast S. cerevisiae CKS1 pombe suc1+ gene products (both about 13 kDa) which interact with the cyclin dependent kinases (cdks). The yeast genes have been shown to be essential for survival, but the exact biologic function of either yeast protein or the mammalian proteins has not been determined. In addition, it is known that the two human protein are encoded by separate, and distinct, gene loci. The necessity of two separate gene products in humans is also not clear. The Principal Investigator originally identified the S. cerevisiae Cks gene as a high copy number suppressor of temperature-sensitive S. pombe cdc2 and S. cerevisiae cdc28 mutations, the human isoforms, and published a number of structural and genetic studies regarding these proteins. The studies in this proposal are focused on determined the functional relationship between the tow mammalian isoforms as well as examining possible role of these proteins in human disease. To do this several strategies will be used to complement existing data: (1) antisense experiment are proposed to assess the phenotypic consequences of eliminating the function of Cks isoforms in cells in tissue culture, individually and together; (2) in parallel, Cks gene knockout in mice will be created to investigate the role (s) and essential nature of Cks protein (s) during developing development; (3) both two-hybrid and biochemical studies will be employed t identify downstream targets of the Cks proteins; and (4) the human Cks genes will be mapped to chromosomal loci as a first step in determining whether disruption of their function genetically might be associated with human disease.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA074224-03
Application #
2871958
Study Section
Human Embryology and Development Subcommittee 1 (HED)
Program Officer
Spalholz, Barbara A
Project Start
1997-04-18
Project End
2002-01-31
Budget Start
1999-02-01
Budget End
2000-01-31
Support Year
3
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Mu, Ruiling; Tat, John; Zamudio, Robert et al. (2017) CKS Proteins Promote Checkpoint Recovery by Stimulating Phosphorylation of Treslin. Mol Cell Biol 37:
del Rincón, S V; Widschwendter, M; Sun, D et al. (2015) Cks overexpression enhances chemotherapeutic efficacy by overriding DNA damage checkpoints. Oncogene 34:1961-7
Teixeira, Leonardo K; Reed, Steven I (2013) Ubiquitin ligases and cell cycle control. Annu Rev Biochem 82:387-414
Pan, Yen-Ru; Sun, Michael; Wohlschlegel, James et al. (2013) Cks1 enhances transcription efficiency at the GAL1 locus by linking the Paf1 complex to the 19S proteasome. Eukaryot Cell 12:1192-201
Liberal, Vasco; Martinsson-Ahlzen, Hanna-Stina; Liberal, Jennifer et al. (2012) Cyclin-dependent kinase subunit (Cks) 1 or Cks2 overexpression overrides the DNA damage response barrier triggered by activated oncoproteins. Proc Natl Acad Sci U S A 109:2754-9
Martinsson-Ahlzen, Hanna-Stina; Liberal, Vasco; Grunenfelder, Bjorn et al. (2008) Cyclin-dependent kinase-associated proteins Cks1 and Cks2 are essential during early embryogenesis and for cell cycle progression in somatic cells. Mol Cell Biol 28:5698-709
Xu, Kui; Belunis, Charles; Chu, Wei et al. (2003) Protein-protein interactions involved in the recognition of p27 by E3 ubiquitin ligase. Biochem J 371:957-64
Spruck, Charles H; de Miguel, Maria P; Smith, Adrian P L et al. (2003) Requirement of Cks2 for the first metaphase/anaphase transition of mammalian meiosis. Science 300:647-50
Spruck, Charles H; Strohmaier, Heimo M (2002) Seek and destroy: SCF ubiquitin ligases in mammalian cell cycle control. Cell Cycle 1:250-4
Spruck, C; Strohmaier, H; Watson, M et al. (2001) A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1. Mol Cell 7:639-50